摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2,5-dimethyl-1-(4-methylphenyl)-1H-pyrrol-3-yl]-2-(piperidin-1-yl)ethanone

中文名称
——
中文别名
——
英文名称
1-[2,5-dimethyl-1-(4-methylphenyl)-1H-pyrrol-3-yl]-2-(piperidin-1-yl)ethanone
英文别名
1-[2,5-dimethyl-1-(4-methylphenyl)pyrrol-3-yl]-2-piperidin-1-ylethanone
1-[2,5-dimethyl-1-(4-methylphenyl)-1H-pyrrol-3-yl]-2-(piperidin-1-yl)ethanone化学式
CAS
——
化学式
C20H26N2O
mdl
——
分子量
310.4
InChiKey
MBPROHMRLWZAEI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    25.2
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • COMPOSITIONS AND METHODS FOR ENHANCING PROTEASOME ACTIVITY
    申请人:President and Fellows of Harvard College
    公开号:EP2528911B1
    公开(公告)日:2017-10-25
  • US20140275169A1
    申请人:——
    公开号:US20140275169A1
    公开(公告)日:2014-09-18
  • USP14 Inhibitors for Treating or Preventing Viral Infections
    申请人:PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    公开号:US20150335652A1
    公开(公告)日:2015-11-26
    Disclosed herein are methods of treating or preventing a viral infection resulting from infection by a flavivirus, comprising administering to a subject a small molecule inhibitor of USP14, represented by Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, chemically-protected form, enantiomer or stereoisomer thereof, and pharmaceutical compositions comprising an effective amount of a compound of Formula (I) for use in the method.
  • Compositions and Methods for Enhancing Proteasome Activity
    申请人:President and Fellows of Harvard College
    公开号:US20160214989A1
    公开(公告)日:2016-07-28
    Proteinopathies result from the proteasome not acting efficiently enough to eliminate harmful proteins and prevent the formation of the pathogenic aggregates. As described herein, inhibition of proteasome-associated deubiquitinase Usp14 results in increased proteasome efficiency. The present invention therefore provides novel compositions and methods for inhibition of Usp14, enhancement of proteasome activity and treatment of proteinopathies.
查看更多